Dualsystems
Publication and more
We identify targets / off-targets of your ligand
If you want to get support for your project
LRC-TriCEPS customers worldwide
Over 200 satisfied customers from 28 countries.
LRC-TriCEPS publications worldwide
Contact form
Please fill out all mandatory (*) fields.
Footer
Social Media
LRC-TriCEPS target identification on living cells – can it be replaced by AI?
Can AI replace LRC-TriCEPS for target discovery on living cells? See how Boltz-2.1 performed across four validated real-life projects.
How LRC-TriCEPS Identified LPHN2 as the Receptor for LRG1
Discover how LRC-TriCEPS identified LPHN2 as the receptor for LRG1 and enabled new research into diabetic vascular and nerve repair pathways.
Collaboration with aTyr Pharma Announces Research
Dualsystems Biotech is very excited to start a 3 year non-exclusive collaboration with aTyr Pharma to identify 10 novel therapeutic drug targets.
With our LRC-TriCEPS platform we can identify targets on living cells and have identified in the past many novel interactions.